GRO Biosciences
GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies.
Boston, United States
32 employees
Series B
Total: $92.62M
Biotechnology, Health Care +2
General Information
Get notified when GRO Biosciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track GRO Biosciences
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
About GRO Biosciences
Taxonomy: Protein Therapeutics, Synthetic Biology, Genomic Recoding, Computational Protein Design, Life Sciences, Bacterial Engineering, Medical Research, Drug Development, Biologics, Healthcare Innovation
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 6 |
|
19 Jul 2024 |
| Series A | •••••• | 5 |
|
01 Nov 2021 |
| Grant | •••••• | 1 |
|
14 Sep 2020 |
| Seed Round | •••••• | 8 |
|
13 Mar 2019 |
| Grant | •••••• | 1 |
|
29 Jan 2019 |
GRO Biosciences Alternatives & Competitors
Feeding the world while saving the planet 🐛
Harnessing the power of nature through the limitless potential of insects.
FAQ About GRO Biosciences
Don't just browse. Track.
Signal Tracker monitors GRO Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.